Myocardial production and release of MCP-1 and SDF-1 following myocardial infarction: Differences between mice and man

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Boyle, Andrew J ^a   Yeghiazarians, Yerem ^a   Shih, Henry ^a   Hwang, Joy ^a   Ye, Jianqin ^a   Sievers, Rich ^a   Zheng, Daiwei ^a   Palasubramaniam, Jath ^b   Palasubramaniam, Dharshan ^b   Karschimkus, Connie ^b   Whitbourn, Robert ^b   Jenkins, Alicia ^b   Wilson, Andrew M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; MESSENGER RNA;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY SINUS BLOOD FLOW; CYTOKINE RELEASE; HEART INFARCTION; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; SYSTEMIC CIRCULATION; UNSTABLE ANGINA PECTORIS; UPREGULATION; ANIMAL; C57BL MOUSE; DEMOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; METABOLISM; MIDDLE AGED; PATHOLOGY; SECRETION; TIME;

AGED; ANIMALS; CHEMOKINE CCL2; CHEMOKINE CXCL12; DEMOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; RNA, MESSENGER; TIME FACTORS;

EID: 80052561904     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-150     Document Type: Article

References (26)

1. Wei Y, Tang Y, Li J, Cui C, Zhang H, Zhang X, Zhang H, Hu S. Cloning and expression pattern of dog SDF-1 and the implications of altered expression of SDF-1 in ischemic myocardium. Cytokine 2007, 40:52-59. 10.1016/j.cyto.2007.08.004, 17910919.
2. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal Cell-Derived Factor-1{alpha} Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury. Circulation 2004, 110:3300-3305. 10.1161/01.CIR.0000147780.30124.CF, 15533866.
3. Vandervelde S, van Luyn MJA, Tio RA, Harmsen MC. Signaling factors in stem cell-mediated repair of infarcted myocardium. Journal of Molecular and Cellular Cardiology 2005, 39:363-376. 10.1016/j.yjmcc.2005.05.012, 15992820.
4. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. The Lancet 2003, 362:697-703.
5. Pillarisetti K, Gupta S. Cloning and Relative Expression Analysis of Rat Stromal Cell Derived Factor-1 (SDF-1): SDF-1 α mRNA Is Selectively Induced in Rat Model of Myocardial Infarction. Inflammation 2001, 25:293-300. 10.1023/A:1012808525370, 11820456.
6. Ma J, Ge J, Zhang S, Sun A, Shen J, Chen L, Wang K, Zou Y. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Research in Cardiology 2005, 100:217-223. 10.1007/s00395-005-0521-z, 15754085.
7. Vandervelde S, van Luyn MJA, Rozenbaum MH, Petersen AH, Tio RA, Harmsen MC. Stem cell-related cardiac gene expression early after murine myocardial infarction. Cardiovascular Research 2007, 73:783-793. 10.1016/j.cardiores.2006.11.030, 17208206.
8. Lee BC, Hsu HC, Tseng WYI, Su MYM, Chen SY, Wu YW, Chien KL, Chen MF. Effect of cardiac rehabilitation on angiogenic cytokines in postinfarction patients. Heart 2009, 95:1012-1018. 10.1136/hrt.2008.153510, 19304668.
9. Wang Y, Johnsen HE, Mortensen S, Bindslev L, Sejersten Ripa R, Haack-Sorensen M, Jorgensen E, Fang W, Kastrup J. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 2006, 92:768-774. 1860647, 16251230.
10. Leone AM, Rutella S, Bonanno G, Contemi AM, de Ritis DG, Giannico MB, Rebuzzi AG, Leone G, Crea F. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. International Journal of Cardiology 2006, 111:202-208. 10.1016/j.ijcard.2005.06.043, 16051386.
11. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor-Deficient Mice. Molecular Cell 1998, 2:275-281. 10.1016/S1097-2765(00)80139-2, 9734366.
12. Zhong L, Chen WQ, Ji XP, Zhang M, Zhao YX, Yao GH, Zhang PF, Zhang C, Zhang Y. Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels. Journal of Cellular and Molecular Medicine 2008, 12:2362-2371. 10.1111/j.1582-4934.2008.00261.x, 18266972.
13. Birdsall HH, Green DM, Trial J, Youker KA, Burns AR, MacKay CR, LaRosa GJ, Hawkins HK, Smith CW, Michael LH, et al. Complement C5a, TGF-fl1, and MCP-1, in Sequence, Induce Migration of Monocytes Into Ischemic Canine Myocardium Within the First One to Five Hours After Reperfusion. Circulation 1997, 95:684-692.
14. Hayashidani S, Tsutsui H, Shiomi T, Ikeuchi M, Matsusaka H, Suematsu N, Wen J, Egashira K, Takeshita A. Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction. Circulation 2003, 108:2134-2140. 10.1161/01.CIR.0000092890.29552.22, 14517168.
15. Zhang F, Tsai S, Kato K, Yamanouchi D, Wang C, Rafii S, Liu B, Kent KC. Transforming Growth Factor-beta Promotes Recruitment of Bone Marrow Cells and Bone Marrow-derived Mesenchymal Stem Cells through Stimulation of MCP-1 Production in Vascular Smooth Muscle Cells. Journal of Biological Chemistry 2009, 284:17564-17574. 10.1074/jbc.M109.013987, 2719395, 19406748.
16. Xu F, Shi J, Yu B, Ni W, Wu X, Gu Z. Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro. Oncology Reports 2010, 23:1561-1567.
17. Stumpf C, Seybold K, Petzi S, Wasmeier G, Raaz D, Yilmaz A, Anger T, Daniel WG, Garlichs CD. Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction. European Journal of Heart Failure 2008, 10:733-739. 10.1016/j.ejheart.2008.06.007, 18599346.
18. Arakelyan A, Petrkova J, Hermanova Z, Boyajyan A, Lukl J, Petrek M. Serum Levels of the MCP-1 Chemokine in Patients With Ischemic Stroke and Myocardial Infarction. Mediators of Inflammation 2005, 2005:175-179. 10.1155/MI.2005.175, 1526470, 16106105.
19. Murakami Y, Kurosaki K, Matsui K, Shimada K, Ikeda U. Serum MCP-1 and VEGF Levels are not Affected by Inhibition of the Renin-Angiotensin System in Patients with Acute Myocardial Infarction. Cardiovascular Drugs and Therapy 2003, 17:249-255. 10.1023/A:1026128308440, 14574083.
20. Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, Matsushima K, Sasayama S. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 1997, 29:419-423. 10.1006/jmcc.1996.0285, 9040055.
21. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes. Circulation 2003, 107:690-695. 10.1161/01.CIR.0000049742.68848.99, 12578870.
22. Yeghiazarians Y, Zhang Y, Prasad M, Shih H, Saini SA, Takagawa J, Sievers RE, Wong ML, Kapasi NK, Mirsky R, et al. Injection of Bone Marrow Cell Extract Into Infarcted Hearts Results in Functional Improvement Comparable to Intact Cell Therapy. Molecular Therapy 2009, 17:1250-1256. 10.1038/mt.2009.85, 2835212, 19384293.
23. Aiuti A, Webb IJ, Bleul CC, Springer T, Guttierez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. Journal of Experimental Medicine 1997, 185:111-120. 10.1084/jem.185.1.111, 2196104, 8996247.
24. Elmadbouh I, Haider HK, Jiang S, Idris NM, Lu G, Ashraf M. Ex vivo delivered stromal cell-derived factor-1[alpha] promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. Journal of Molecular and Cellular Cardiology 2007, 42:792-803. 10.1016/j.yjmcc.2007.02.001, 2753220, 17350033.
25. Saxena A, Fish JE, White MD, Yu S, Smyth JWP, Shaw RM, DiMaio JM, Srivastava D. Stromal Cell-Derived Factor-1{alpha} Is Cardioprotective After Myocardial Infarction. Circulation 2008, 117:2224-2231. 10.1161/CIRCULATIONAHA.107.694992, 2743260, 18427137.
26. Frangogiannis NG, Dewald O, Xia Y, Ren G, Haudek S, Leucker T, Kraemer D, Taffet G, Rollins BJ, Entman ML. Critical Role of Monocyte Chemoattractant Protein-1/CC Chemokine Ligand 2 in the Pathogenesis of Ischemic Cardiomyopathy. Circulation 2007, 115:584-592. 10.1161/CIRCULATIONAHA.106.646091, 17283277.